journal
MENU ▼
Read by QxMD icon Read
search

Current Problems in Cardiology

journal
https://www.readbyqxmd.com/read/28764841/non-st-elevation-acute-coronary-syndromes-a-comprehensive-review
#1
Tamunoinemi Bob-Manuel, Ikechuckwu Ifedili, Guy Reed, Uzoma N Ibebuogu, Rami N Khouzam
Non-ST elevation-acute coronary syndrome (NSTE-ACS) includes NSTE myocardial infarction and unstable angina. This patient population forms approximately two-thirds of all hospital admissions for ACS in the United States each year and is associated with an in-hospital mortality of 5%. NSTE-ACS is primarily due to an acute change in the supply and demand balance of coronary perfusion and myocardial oxygen consumption, because of the significant coronary artery obstruction presenting as plaque rupture or erosion...
September 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28764840/foreword
#2
(no author information available yet)
No abstract text is available yet for this article.
September 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28709475/evolution-of-american-academic-medicine-a-view-of-its-contributions-to-world-medicine-and-reflections-influenced-by-personal-role-models
#3
Edward D Frohlich
The changes in American academic medicine in the last 6 decades has been a success. During these years, I participated in this development through patients care, research, editorship of major Journals and as a member of governing boards of several professional organizations. This discussion will describe some of the developments of medicine and will recount my own professional career and my mentors who help me to achieve my goals.
August 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28709474/foreword
#4
Hector O Ventura
No abstract text is available yet for this article.
August 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28552207/clinical-perspective-on-antihypertensive-drug-treatment-in-adults-with-grade-1-hypertension-and-low-to-moderate-cardiovascular-risk-an-international-expert-consultation
#5
REVIEW
Alberto Morales Salinas, Antonio Coca, Michael H Olsen, Ramiro A Sanchez, Weimar K Sebba-Barroso, Richard Kones, Vicente Bertomeu-Martinez, Javier Sobrino, Luis Alcocer, Daniel J Pineiro, Fernando Lanas, Carlos A Machado, Fernando Aguirre-Palacios, Jose Ortellado, Gonzalo Perez, Rodrigo Sabio, Orlando Landrove, Delfin Rodriguez-Leyva, Alfredo Duenas-Herrera, Ayelen Rodriguez Portelles, Jose Z Parra-Carrillo, Daniel L Piskorz, Alfonso Bryce-Moncloa, Gabriel Waisman, Yuichiro Yano, Hector Ventura, Marcelo Orias, Dorairaj Prabhakaran, J Sundström, Jiguang Wang, Louise M Burrell, Alta E Schutte, Patricio Lopez-Jaramillo, Eduardo Barbosa, Josep Redon, Michael A Weber, Carl J Lavie, Agustin Ramirez, Pedro Ordunez, Salim Yusuf, Alberto Zanchetti
Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99mmHg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts. After holistic analysis of all epidemiological, clinical, psychosocial, and public health elements, this consultation process reached the following consensus in hypertensive adults aged <80 years: (1) The question of whether drug treatment in grade 1 should be preceded by a period of some weeks or months during which only lifestyle measures are recommended cannot be evidence based, but the consensus opinion is to have a period of lifestyle alone reserved only to patients with grade 1 "isolated" hypertension (grade 1 uncomplicated hypertension with low absolute total CVR, and without other major CVR factors and risk modifiers)...
July 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28552206/how-low-is-too-high-at-what-value-should-we-start-treating-hypertension
#6
Eiman Jahangir
No abstract text is available yet for this article.
July 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28454639/shorter-door-to-balloon-st-elevation-myocardial-infarction-time-should-there-be-a-minimum-limit
#7
Sameh Askandar, Tamunoinemi Bob-Manuel, Pahul Singh, Rami N Khouzam
In ST-elevation myocardial infarction (STEMI) ischemic time is directly related to permanent myocardial damage and mortality. Therefore, it is crucial to restore myocardial perfusion rapidly. Door-to-balloon (DTB) time is defined as the duration between the arrival time of the patient to the medical facility until the time he or she is treated with percutaneous coronary intervention. Currently, DTB is the criterion that measures the quality of care provided to patients with STEMI at any given institution. It is well documented in the literature that longer DTB is associated with higher mortality; however, lowering DTB beyond current recommendations has not shown to decrease mortality rates...
June 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28454638/foreword
#8
Hector Ventura
No abstract text is available yet for this article.
June 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28363584/upper-gastrointestinal-toxicity-associated-with-long-term-aspirin-therapy-consequences-and-prevention
#9
REVIEW
Carl J Lavie, Colin W Howden, James Scheiman, James Tursi
Antiplatelet therapy represents a fundamental part of preventive management for patients who are at risk of a secondary cardiovascular disease (CVD) event. In most cases, the antiplatelet regimen is based on low-dose aspirin, a drug that is highly effective in reducing the incidence of CVD events, but is associated with a substantial risk of gastrointestinal (GI) toxicity. The dyspeptic symptoms, which can result from aspirin administration, and which may occur with or without associated ulceration and bleeding, may lead patients to discontinue therapy, thus increasing their CVD risk...
May 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28363583/foreword
#10
(no author information available yet)
No abstract text is available yet for this article.
May 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28325353/renal-artery-stenosis-when-to-revascularize-in-2017
#11
REVIEW
Jose D Tafur, Christopher J White
Atherosclerotic renal artery stenosis is the leading cause of secondary hypertension; it can also cause progressive renal insufficiency and cardiovascular complications such as refractory heart failure and flash pulmonary edema. Medical therapy including risk factor modification, renin-angiotensin-aldosterone system antagonists, lipid lowering agents, and antiplatelet therapy is the first line of treatment in all patients. Patients with uncontrolled renovascular hypertension despite optimal medical therapy, ischemic nephropathy, and cardiac destabilization syndromes who have severe renal artery stenosis are likely to benefit from renal artery revascularization...
April 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28325352/foreword
#12
Hector Ventura
No abstract text is available yet for this article.
April 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28232004/echocardiographic-assessment-of-degenerative-mitral-stenosis-a-diagnostic-challenge-of-an-emerging-cardiac-disease
#13
REVIEW
Ahmet Afşşin Oktay, Yvonne E Gilliland, Carl J Lavie, Stephen J Ramee, Patrick E Parrino, Michael Bates, Sangeeta Shah, Michael E Cash, Homeyar Dinshaw, Salima Qamruddin
Degenerative mitral stenosis (DMS) is characterized by decreased mitral valve (MV) orifice area and increased transmitral pressure gradient due to chronic noninflammatory degeneration and subsequent calcification of the fibrous mitral annulus and the MV leaflets. The "true" prevalence of DMS in the general population is unknown. DMS predominantly affects elderly individuals, many of whom have multiple other comorbidities. Transcatheter MV replacement techniques, although their long-term outcomes are yet to be tested, have been gaining popularity and may emerge as more effective and relatively safer treatment option for patients with DMS...
March 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28232003/foreword
#14
EDITORIAL
Hector Ventura
No abstract text is available yet for this article.
March 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28104044/procedural-variations-in-performing-primary-percutaneous-coronary-intervention-in-patients-with-st-elevation-myocardial-infarction
#15
REVIEW
Radhika M Mehta, Manyoo Agarwal, Ikechukwu Ifedili, Wael W Rizk, Rami N Khouzam
Multiple variations exist in performing a primary percutaneous coronary intervention (pPCI) in ST-segment elevation myocardial infarction (STEMI) among various cardiologists. These variations range from the choice of peripheral access artery (radial vs femoral), performance or time of complete angiography including left ventriculography, and nonculprit vessel angiography before or after intervening on the culprit vessel. The reasons for such variations include emphasis on door-to-balloon time, knowledge of cardiac anatomy before proceeding with pPCI, physician expertise, and the level of comfort with radial approach...
February 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/28104043/foreword
#16
(no author information available yet)
No abstract text is available yet for this article.
February 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/27989311/an-update-on-the-management-of-chronic-thromboembolic-pulmonary-hypertension
#17
REVIEW
Justin A Edward, Stacy Mandras
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening form of pulmonary artery hypertension that is defined as a mean arterial pulmonary pressure greater than 25mmHg that persists for more than 6 months following anticoagulation therapy in the setting of pulmonary emboli. CTEPH is categorized by the World Health Organization as group IV pulmonary hypertension and is thought to be due to unresolved thromboemboli in the pulmonary artery circulation. Among the 5 classes of pulmonary hypertension, CTEPH is unique in that it is potentially curable with the use of pulmonary thromboendarterectomy surgery...
January 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/27989310/foreword
#18
Hector O Ventura
No abstract text is available yet for this article.
January 2017: Current Problems in Cardiology
https://www.readbyqxmd.com/read/27914522/the-validity-of-us-nutritional-surveillance-usda-s-loss-adjusted-food-availability-data-series-1971-2010
#19
Edward Archer, Diana M Thomas, Samantha M McDonald, Gregory Pavela, Carl J Lavie, James O Hill, Steven N Blair
The purpose of this study was to examine the validity of the 1971-2010 United States Department of Agriculture's (USDA's) loss-adjusted food availability (LAFA) per capita caloric consumption estimates. Estimated total daily energy expenditure (TEE) was calculated for nationally representative samples of US adults, 20-74 years, using the Institute of Medicine's predictive equations with "low-active" (TEE L-ACT) and "sedentary" (TEE SED) physical activity values. TEE estimates were subtracted from LAFA estimates to create disparity values (kcal/d)...
November 2016: Current Problems in Cardiology
https://www.readbyqxmd.com/read/27914521/foreword
#20
Hector O Ventura
No abstract text is available yet for this article.
November 2016: Current Problems in Cardiology
journal
journal
26962
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"